Opdivo User Reviews & Ratings (Page 4)
Opdivo has an average rating of 5.3 out of 10 from a total of 80 reviews on Drugs.com. 44% of reviewers reported a positive experience, while 48% reported a negative experience.
Reviews for Opdivo
- Anonymous
- July 17, 2017
For Non Small Cell Lung Cancer "My brother died from taking this medication. His cancer was in his lungs. When he started opdivo, the cancer quickly went to his brain. He died weeks later. Why did the FDA approve this drug?"
- Rosebud
- Taken for 1 to 6 months
- November 19, 2017
For Melanoma "My Husband has had wonderful success with this medicine it never made him sick the whole time he has been taking it. He is presently still on it for maintaince"
Frequently asked questions
- How long does Opdivo prolong life and what’s its success rate?
- What are monoclonal antibodies?
- How long does Opdivo take to work and how do you know if it's working?
- What is the difference between Opdivo and Keytruda?
- Anonymous
- Taken for 2 to 5 years
- May 24, 2020
For Non Small Cell Lung Cancer "My mom has stage 4 nslc on year 7. She started Opdivo 4 years ago and at age 74 she’s still going strong. Minimal side effects cancer is almost non existent."
- Kim...
- Taken for 1 to 2 years
- January 29, 2023
For Renal Cell Carcinoma "Renal metastatic cancer in back and lungs also worked terrific going on 6 years cancer free."
Are you taking this medicine?
- Rayray
- Taken for 1 to 6 months
- March 2, 2017
For Non Small Cell Lung Cancer "My mother died from lung cancer. Her last hope of this medication. Within a couple months she was gone"
- Richard
- March 9, 2023
For Colorectal Cancer "Cancer has decreased from 26mm to 8 mm. Experienced diarrhea daily, need to drink lots of water, occasional dizziness, trouble focusing on written words on computer, fatigue."
More FAQ
- Pembrolizumab vs. nivolumab: How do they compare?
- How long does Opdivo stay in your system?
- What happens when you stop taking Opdivo for melanoma?
- Is Opdivo a chemotherapy or immunotherapy drug?
- JJano
- Taken for less than 1 month
- February 13, 2021
For Head and Neck Cancer "These drugs poisoned my best friend. He had been doing well and after 2 treatments with these drugs he is a dying vegetable"
- Bob
- Taken for 2 to 5 years
- June 27, 2023
For Renal Cell Carcinoma "Drug is being administered by infusion every 28 days for about two years. No sign of cancer for many months in my CT scans."
- sdwoods
- Taken for less than 1 month
- February 26, 2024
For Renal Cell Carcinoma "So far, so good. I have only had one infusion and no side effects. A couple more months and I will have a PET scan. Will know more then. I also have psoriasis so some immunology difficulties."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Opdivo (nivolumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
For Renal Cell Carcinoma "I was on Opdivo for 6 months. It really set me back, I had to quit it before it killed me."